
|Videos|October 17, 2022
The Role of Adjuvant Immunotherapy in the Treatment of Resectable NSCLC
Vamsidhar Velcheti, MD, summarizes recent data on adjuvant immunotherapy treatment in resectable NSCLC.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on OncLive
1
ST-001 nanoFenretinide Shows Antitumor Activity in Previously Treated Cutaneous T-Cell Lymphoma
2
Immune and Single-Cell Profiling Reveals Drivers of Mogamulizumab Resistance in Mycosis Fungoides and Sézary Syndrome
3
Dibotatug Is Safe and Shows Activity in R/R Cytotoxic T/NK Cell Lymphomas
4
Pegylated Interferon Alfa-2a Is Safe and Tolerable in Real-World CTCL Study
5

























































































